Neufeld Leah R

Chief People Officer Leah R Neufeld bought 2,626 shares at $4.15; stock down 49.9% from 52-week high, 3 other insiders bought within 14 days.

Leah R Neufeld, Chief People Officer at Immuneering Corp, purchased 2,626 shares at $4.15 on 2026-01-13, increasing her holdings by 11.2% to 25,970 shares total. This transaction occurs as IMRX trades at $4.64, down 49.9% from its 52-week high and down 19.2% over 30 days, suggesting purchase near recent lows. The filing shows a cluster pattern: 3 other insiders also bought within the past 14 days, which may indicate coordinated confidence at current valuations. However, the company's fundamentals remain challenged—revenue is $0.00 in the latest quarter, annual revenue growth is -100.0%, and net income was negative at -$14,964,875.00, indicating the company is unprofitable and in early-stage or distressed operations. Against this context, multiple insider purchases may reflect either a belief in turnaround prospects or a routine compensation/equity program rather than a market-timing signal.

Chief People Officer Leah R Neufeld buys 800 shares of IMRX at $6.38; cluster pattern with 3 other insiders buying within 14 days

Leah R Neufeld, Chief People Officer, purchased 800 shares at $6.38 on 2025-10-01, expanding her holdings from 22,544 to 23,344 shares. The transaction occurs within a cluster pattern—3 other insiders bought within the past 14 days—suggesting coordinated or near-simultaneous confidence assessment at the leadership level. However, context is mixed: Neufeld's cross-ticker track record shows her prior 2 buys averaged +23.8% over 90 days with a 50% win rate, but at IMRX specifically, her prior buy on 2025-07-02 returned +96.1% at 90 days while her 2024-03-20 buy fell -48.6%, indicating inconsistent stock-specific outcomes. The company operates with $0.00 revenue (latest quarter) and -$14.4M net income, with annual revenue declining -100%, raising fundamental questions about execution and near-term path to profitability that investors should weigh against insider accumulation patterns.

IMRX CPO Neufeld buys 700 shares at $3.57 (2024-03-20 prior buy: -48.6% at 90d); stock now $4.05. 4-insider cluster.

Leah R Neufeld, Chief People Officer at Immuneering, purchased 700 shares at $3.57 on 2025-07-02, raising her holdings to 10,729 shares from 10,029 shares. The company is unprofitable with net income of $-15,046,132.00 and zero revenue in the latest quarter, and experienced -100.0% annual revenue growth. Neufeld's prior buy at this ticker on 2024-03-20 posted -48.6% return at the 90-day mark, and her cross-ticker track record shows 0 of 1 prior buys were well-timed at 90 days with an average 90-day return of -48.6%. The current stock price of $4.05 is at its 52-week high but remains below her prior entry price adjusted for time, and this transaction occurs within a 4-insider cluster buy pattern in the past 14 days—a coordinated activity worth noting in the context of a deeply unprofitable, zero-revenue company.